UNSPSC 51382701: Oxindanac

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZY400R3BNT. European Medicines Agency schedules Oxindanac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09532MIG. Oxindanac generally arises in the molecular formula C17H14O4.

The term OXINDANAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, no. 6, 1986, list 26.) OXINDANAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, OXINDANAC remains the US FDA Preferred Term for this commodity. Oxindanac bears US NLM identifiers UMLS ID C0069768 and NCI Concept Code C66268. SMILES: OC(=O)C1CCC2C1CC(O)C(C2)C(=O)C1CCCCC1.

UNSPSC 51382701 Oxindanac (Commodity) represents a narrow pharmaceutical product line, though the recent state and local activity shows a mismatch between the code's nominal scope and actual procurement. The single recorded opportunity under this code is Seminole County, Florida's IFB for Naloxone and Safe Drug Deactivation Systems (IFB 60459723LAS, posted June 30, 2026, response due July 26, 2026), which centers on emergency-response pharmaceuticals and harm-reduction equipment rather than oxindanac as a chemical compound. The county sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems on an annual basis with quarterly deliveries to the Seminole County Community Health Building. The work is driven by community health initiatives and requires vendors to handle all shipping and delivery, submit bids electronically, provide unit costs per line item, and maintain workers' compensation, commercial general liability, and professional liability insurance. Vendors must meet E-Verify compliance, pass drug-free workplace certification, and accept a probationary three-month termination-at-will period. The contract term is two years with a one-year renewal option, and the procurement appears to draw federal funding through FEMA, introducing Clean Air Act and Federal Water Pollution Control Act compliance obligations.

The code shows no pattern of sustained state or local purchasing activity beyond the Seminole County solicitation. Florida is the only state represented in the recent record, and the issuing body is a single county health procurement. The mismatch between the code's chemical-compound title and the actual commodities being sought—emergency-response drugs and drug-disposal systems—suggests either a misclassification by the source or a narrow, ad-hoc use of the UNSPSC code that does not reflect broader category demand. Business development professionals should note that this Commodity code does not currently signal an active or recurring market among state and local agencies; the single documented opportunity may be specific to Seminole County's opioid-response initiative rather than a systemic procurement pattern.